Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma

JC Chambers, WH Zhang, J Sehmi, XZ Li, MN Wass, P van der Harst, H Holm, S Sanna, Maryam Kavousi, SE Baumeister, LJ Coin, GH Deng, C Gieger, NL Heard-Costa, JJ (Jouke Jan) Hottenga, B Kuhnel, V Kumar, V Lagou, LM Liang, JA LuanPM Vidal, IM Leach, PF O'Reilly, JF Peden, N Rahmioglu, P Soininen, EK Speliotes, X Yuan, G Thorleifsson, BZ Alizadeh, LD Atwood, IB Borecki, MJ Brown, P Charoen, F Cucca, Devashish Das, EJC de Geus, AL Dixon, A Doering, G Ehret, GI Eyjolfsson, M Farrall, NG Forouhi, N Friedrich, W Goessling, DF Gudbjartsson, TB Harris, AL Hartikainen, S Heath, GM Hirschfield, Bert Hofman, G Homuth, E Hypponen, HLA Janssen, T Johnson, AJ Kangas, IP Kema, JP Kuhn, S Lai, M Lathrop, MM Lerch, Yunlei Li, TJ Liang, JP Lin, RJF Loos, NG Martin, MF Moffatt, GW Montgomery, PB Munroe, K Musunuru, Y Nakamura, CJ O'Donnell, I Olafsson, BW Penninx, A Pouta, BP Prins, I Prokopenko, R Puls, A Ruokonen, MJ Savolainen, D Schlessinger, Jeoffrey Schouten, U Seedorf, S Sen-Chowdhry, KA Siminovitch, JH Smit, TD Spector, WT Tan, TM Teslovich, T Tukiainen, André Uitterlinden, MM (Melanie) van der Klauw, RS Vasan, C Wallace, H Wallaschofski, HE Wichmann, G Willemsen, P Wurtz, C Xu, LM Yerges-Armstrong, GR Abecasis, KR Ahmadi, DI Boomsma, M Caulfield, WO Cookson, Cornelia Duijn, P Froguel, K Matsuda, MI McCarthy, C Meisinger, V Mooser, KH Pietilainen, G Schumann, H Snieder, MJE Sternberg, RP (Ronald) Stolk, HC Thomas, U Thorsteinsdottir, M Uda, G Waeber, NJ Wareham, DM Waterworth, H Watkins, JB Whitfield, JCM Witteman, BHR Wolffenbuttel, CS Fox, M Ala-Korpela, K Stefansson, P Vollenweider, H Volzke, EE Schadt, J Scott, MR Jarvelin, P Elliott, JS Kooner

Research output: Contribution to journalArticleAcademicpeer-review


Concentrations of liver enzymes in plasma are widely used as indicators of liver disease. We carried out a genome-wide association study in 61,089 individuals, identifying 42 loci associated with concentrations of liver enzymes in plasma, of which 32 are new associations (P = 10(-8) to P = 10(-190)). We used functional genomic approaches including metabonomic profiling and gene expression analyses to identify probable candidate genes at these regions. We identified 69 candidate genes, including genes involved in biliary transport (ATP8B1 and ABCB11), glucose, carbohydrate and lipid metabolism (FADS1, FADS2, GCKR, JMJD1C, HNF1A, MLXIPL, PNPLA3, PPP1R3B, SLC2A2 and TRIB1), glycoprotein biosynthesis and cell surface glycobiology (ABO, ASGR1, FUT2, GPLD1 and ST3GAL4), inflammation and immunity (CD276, CDH6, GCKR, HNF1A, HPR, ITGA1, RORA and STAT4) and glutathione metabolism (GSTT1, GSTT2 and GGT), as well as several genes of uncertain or unknown function (including ABHD12, EFHD1, EFNA1, EPHA2, MICAL3 and ZNF827). Our results provide new insight into genetic mechanisms and pathways influencing markers of liver function.
Original languageUndefined/Unknown
Pages (from-to)1131-U129
JournalNature Genetics
Issue number11
Publication statusPublished - 2011

Cite this